The use and safety of doxycycline hyclate and other second-generation tetracyclines

@article{Sloan2008TheUA,
  title={The use and safety of doxycycline hyclate and other second-generation tetracyclines},
  author={Barry Sloan and Noah S. Scheinfeld},
  journal={Expert Opinion on Drug Safety},
  year={2008},
  volume={7},
  pages={571 - 577}
}
Tetracyclines have long been used to treat a wide variety of medical conditions, especially in the field of dermatology. Unfortunately, safety concerns, especially gastrointestinal (GI), have always been present. Other safety concerns have included tooth development in children, candidiasis, vestibular concerns, photosensitivity/phototoxicity, and more unusual adverse effects such as uncontrolled hypertension. This article first discusses the pharmacological development of the tetracyclines… 

Safety and Efficacy Review of Doxycycline

Doxycycline is a member of the tetracycline class of antibiotics and has been used clinically for more than 40 years. It is a well-tolerated drug that is bacteriostatic and acts via the inhibition of

Doxycycline in the management of sexually transmitted infections

In light of increasing prevalence of resistance towards first-line regimens of some STI agents and recently updated recommendations for STI management, doxycycline appears to be an attractive option compared with other available antibiotics for the treatment of someSTD due to its efficacy, good tolerability and oral administration.

Modern ways of doxicycline delivery and prospects of application in pharmacy

Doxycycline is promising in pharmaceutical practice for the treatment of COVID-19, both due to its ability to inhibit matrix metalloproteinases (MMPs) and antiviral activity, especially against Mycoplasma pneumoniae, which is a secondary bacterial cause of pneumonia during the CO VID-19 pandemic.

Efficacy and safety of tetracyclines for pemphigoid: a systematic review and meta-analysis

Compared to doxycycline and minocycline, tetracycline was significantly associated with better treatment outcomes and fewer adverse effects and may offer support for clinical use of tetrACYclines in pemphigoid.

An Integrated Safety Summary of Omadacycline, a Novel Aminomethylcycline Antibiotic

Similar to most tetracyclines, transient nausea and vomiting and low-magnitude increases in liver aminotransferases were the most frequent treatment-emergent adverse events in phase III studies but were not treatment limiting.

Minocycline for acne vulgaris: efficacy and safety.

Although minocycline was shown to be an effective treatment for moderate to moderately-severe acne vulgaris, there was no evidence that it is better than any of the other commonly-used acne treatments.

Azithromycin in periodontal treatment: more than an antibiotic.

Azithromycin could have a triple role in the treatment and resolution of periodontal diseases: suppressing periodontopathogens, anti-inflammatory activity and healing through persistence at low levels in macrophages and fibroblasts inperiodontal tissues, even after a single course of three tablets.

Side effects of common acne treatments

A systematic literature review was performed to identify publications discussing the side effects of the different treatment modalities used for acne vulgaris and the best available options are those that address acne severity while minimizing side effects for the patient.

The Impact of Long-Term Antibiotic Therapy of Cutaneous Adverse Reactions to EGFR Inhibitors in Colorectal Cancer Patients

The aim was to perform a thorough literature review and discuss the main challenges raised by long-term use of tetracyclines in advanced CRC patients receiving this targeted therapy.
...

References

SHOWING 1-10 OF 35 REFERENCES

A status report on the use of subantimicrobial-dose doxycycline: a review of the biologic and antimicrobial effects of the tetracyclines.

Enhanced understanding of inflammatory pathways in epithelial and mesenchymal tissues has revealed that the use of subantimicrobial doses of doxycycline initiates anti-inflammatory activity that correlates with clinical efficacy in acne vulgaris and rosacea.

Second-generation tetracyclines, a dermatologic overview: clinical uses and pharmacology.

The important pharmacologic and microbiological characteristics of these three commonly used second-generation tetracyclines minocycline, doxycycline hyclate, and doxy cycline monohydrate are reviewed, and their clinical applications in dermatology are reviewed.

Recently approved systemic therapies for acne vulgaris and rosacea.

The studies and clinical applications related to the use of tetracycline derivatives and minocycline was discussed, based on large-scale phase 3 pivotal trials and long-term microbiologic and safety data.

Recently approved systemic therapies for acne vulgaris and rosacea.

The studies and clinical applications related to the use of tetracycline derivatives and minocycline was discussed, based on large-scale phase 3 pivotal trials and long-term microbiologic and safety data.

Safety and efficacy of a new extended-release formulation of minocycline.

It was concluded that a novel ER-minocycline formulation that delivers consistent levels of drug at a 1-mg/kg dose reduces dose-dependent AVAEs while reducing inflammatory lesions and improving the overall appearance of patients with acne vulgaris.

Interaction of Doxycycline and Warfarin: An Enhanced Anticoagulant Effect

Doxycycline can enhance the anticoagulant effect of warfarin and is likely due to competitive interaction for albumin binding and possibly inhibition of the cytochrome P-450 system.

Porphyria-like cutaneous changes induced by tetracycline hydrochloride photosensitization.

Five patients manifested cutaneous changes indistinguishable from those noted in some porphyric disorders, consisting of fragility, denudation, and blister formation of sun-exposed skin, which were concluded to result from a low-grade photosensitization by tetracycline hydrochloride.

Evaluation of Periostat for patient management.

  • J. Caton
  • Medicine
    Compendium of continuing education in dentistry
  • 1999
The clinical trial results leading to US Food and Drug Administration approved of Periostat are reviewed and the potential use of this host-modulatory agent as a complementary systemic pharmacotherapy in periodontal management programs is discussed.

Acute hepatitis and exfoliative dermatitis associated with minocycline.

The often repeated implication that shortening working hours necessarily requires a lengthened training programme is incorrect, based on a recent experience of a four year residency training scheme at a Canadian teaching hospital.